| Literature DB >> 24994934 |
Benjamin Förstera1, Omar Dzaye2, Aline Winkelmann3, Marcus Semtner1, Bruno Benedetti4, Darko S Markovic5, Michael Synowitz6, Peter Wend7, Michael Fähling8, Marie-Pierre Junier9, Rainer Glass10, Helmut Kettenmann2, Jochen C Meier11.
Abstract
The neuronal function of Cys-loop neurotransmitter receptors is established; however, their role in non-neuronal cells is poorly defined. As brain tumors are enriched in the neurotransmitter glycine, we studied the expression and function of glycine receptors (GlyRs) in glioma cells. Human brain tumor biopsies selectively expressed the GlyR α1 and α3 subunits, which have nuclear localization signals (NLSs). The mouse glioma cell line GL261 expressed GlyR α1, and knockdown of GlyR α1 protein expression impaired the self-renewal capacity and tumorigenicity of GL261 glioma cells, as shown by a neurosphere assay and GL261 cell inoculation in vivo, respectively. We furthermore showed that the pronounced tumorigenic effect of GlyR α1 relies on a new intracellular signaling function that depends on the NLS region in the large cytosolic loop and impacts on GL261 glioma cell gene regulation. Stable expression of GlyR α1 and α3 loops rescued the self-renewal capacity of GlyR α1 knockdown cells, which demonstrates their functional equivalence. The new intracellular signaling function identified here goes beyond the well-established role of GlyRs as neuronal ligand-gated ion channels and defines NLS-containing GlyRs as new potential targets for brain tumor therapies.Entities:
Keywords: Gene regulation; Glioma; Glycine receptor
Mesh:
Substances:
Year: 2014 PMID: 24994934 DOI: 10.1242/jcs.146662
Source DB: PubMed Journal: J Cell Sci ISSN: 0021-9533 Impact factor: 5.285